<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30895/1991-2919-2024-14-3-265-282</article-id><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-630</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННЫХ СРЕДСТВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SAFETY OF MEDICINES</subject></subj-group></article-categories><title-group><article-title>Практические аспекты функциональной оценки токсических поражений периферической нервной системы в доклинических исследованиях на грызунах: обзор</article-title><trans-title-group xml:lang="en"><trans-title>Practical Aspects of Assessing Toxic Lesions of the Peripheral Nervous System in Preclinical Studies in Rodents: A Review</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7406-753X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильинский</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilinskii</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ильинский Никита Сергеевич, канд. мед. наук</p><p>ул. Лесопарковая, д. 4, Санкт-Петербург, 195043</p></bio><bio xml:lang="en"><p>Nikita S. Ilinskii, Cand. Sci. (Med.)</p><p>4 Lesoparkovaya St., St Petersburg 195043</p></bio><email xlink:type="simple">gniiivm_7@mil.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6974-5583</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюнин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyunin</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тюнин Михаил Александрович, канд. мед. наук</p><p>ул. Лесопарковая, д. 4, Санкт-Петербург, 195043</p></bio><bio xml:lang="en"><p>Mikhail A. Tyunin, Cand. Sci. (Med.)</p><p>4 Lesoparkovaya St., St Petersburg 195043</p></bio><email xlink:type="simple">gniiivm_7@mil.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5324-512X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чепур</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chepur</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чепур Сергей Викторович, д-р мед. наук, профессор</p><p>ул. Лесопарковая, д. 4, Санкт-Петербург, 195043</p></bio><bio xml:lang="en"><p>Sergey V. Chepur, Dr. Sci. (Med.), Professor</p><p>4 Lesoparkovaya St., St Petersburg 195043</p></bio><email xlink:type="simple">gniiivm_7@mil.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4290-350X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пугач</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pugach</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пугач Виктория Александровна, канд. биол. наук</p><p>ул. Лесопарковая, д. 4, Санкт-Петербург, 195043</p></bio><bio xml:lang="en"><p>Viktoria A. Pugach, Cand. Sci. (Biol.)</p><p>4 Lesoparkovaya St., St Petersburg 195043</p></bio><email xlink:type="simple">gniiivm_7@mil.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6524-9371</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мясников</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Myasnikov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мясников Вадим Александрович, канд. мед. наук</p><p>ул. Лесопарковая, д. 4, Санкт-Петербург, 195043</p></bio><bio xml:lang="en"><p>Vadim A. Myasnikov, Cand. Sci. (Med.)</p><p>4 Lesoparkovaya St., St Petersburg 195043</p></bio><email xlink:type="simple">gniiivm_7@mil.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Государственный научно-исследовательский испытательный институт военной медицины» Министерства обороны Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Scientific Research Testing Institute of Military Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2024</year></pub-date><volume>14</volume><issue>3</issue><fpage>265</fpage><lpage>282</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ильинский Н.С., Тюнин М.А., Чепур С.В., Пугач В.А., Мясников В.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ильинский Н.С., Тюнин М.А., Чепур С.В., Пугач В.А., Мясников В.А.</copyright-holder><copyright-holder xml:lang="en">Ilinskii N.S., Tyunin M.A., Chepur S.V., Pugach V.A., Myasnikov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/630">https://www.vedomostincesmp.ru/jour/article/view/630</self-uri><abstract><sec><title>ВВЕДЕНИЕ</title><p>ВВЕДЕНИЕ. В практике доклинических исследований безопасности фармакологически активных веществ стандартные процедуры оценки нейротоксичности в основном нацелены на диагностику расстройств высшей нервной деятельности и поведения. Однако именно структуры периферической нервной системы ввиду большей уязвимости представляют собой доступную мишень, что обусловливает высокую распространенность нейротоксичных побочных эффектов лекарственных средств. Указанные обстоятельства определяют актуальность уточнения методических подходов к оценке токсических поражений периферической нервной системы.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Анализ современного методического уровня клинико-функциональных тестов для оценки токсического действия фармакологически активных веществ на структуры периферической нервной системы и формулирование практических рекомендаций по их применению при проведении доклинических исследований на грызунах.</p></sec><sec><title>ОБСУЖДЕНИЕ</title><p>ОБСУЖДЕНИЕ. Оптимальной тест-системой для доклинических исследований фармакологически активных веществ считаются грызуны, однако используя этих животных невозможно воспроизвести весь объем неврологического осмотра, применяемого для выявления клинических эквивалентов нейротоксичности. В работе представлено описание системного подхода к использованию доступных диагностических тестов для повышения транслируемости данных. Дана краткая характеристика неврологического дефицита, вызванного побочными действиями лекарственных средств у людей, и описаны основные токсиндромы, которые также могут быть выявлены у животных. На основании обзора литературы и собственного опыта в соответствующих разделах представлены практические рекомендации по выполнению основных тестов, позволяющих исследовать силу и тонус мышц, состояние физиологических рефлексов, координацию движений и разные виды чувствительности у грызунов. Приведены краткие сведения о возможностях электрофизиологической диагностики искомых поражений. В качестве минимального перечня методик первичного скрининга нейротоксических побочных эффектов рекомендованы следующие тесты: оценка позы животного в покое и при ходьбе «Сужающаяся дорожка», «Подтягивание на горизонтальной перекладине», шкала отведения пальцев, «Тест отдергивания хвоста», рефлекс Прейера.</p></sec><sec><title>ВЫВОДЫ</title><p>ВЫВОДЫ. Анализ результатов комплексной оценки неврологического дефицита в экспериментах на грызунах рекомендовано проводить клинически релевантным способом, то есть с позиций топической диагностики и общности звеньев патологического процесса. Целесообразно выполнять верификацию патологического процесса на уровне периферической нервной системы при помощи комплекса электрофизиологических методик.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>INTRODUCTION</title><p>INTRODUCTION. In the current practice of preclinical safety studies of pharmacologically active substances, standard neurotoxicity assessment procedures are mainly aimed at diagnosing higher nervous activity and behavioural disorders. However, it is the structures of the peripheral nervous system that are particularly susceptible to drug-induced neurotoxicity, which renders these structures an easy target and leads to a high incidence of neurotoxic side effects. These circumstances dictate the importance of refining methodological approaches to the assessment of toxic injury in the peripheral nervous system.</p></sec><sec><title>AIM</title><p>AIM. The study aimed to analyse the current methodological level of clinical and functional tests for assessing the toxic effects of pharmacologically active substances on the structures of the peripheral nervous system, as well as to formulate practical recommendations for using these tests in preclinical studies in rodents.</p></sec><sec><title>DISCUSSION</title><p>DISCUSSION. Rodents are considered the optimal test system for preclinical studies of pharmacologically active substances, but it is impossible to reproduce the entire neurological examination that is conducted to identify clinical equivalents of neurotoxicity in humans using these animals. This article presents a systematic approach to using available diagnostic tests to increase the translatability of data. The article briefly describes the neurological deficits due to adverse drug reactions in humans, as well as the main toxidromes that can also occur in animals. Based on a literature review and experience, the authors provide practical recommendations for performing basic tests to study the strength and tone of muscles, the state of physiological reflexes, the coordination of movements, and various types of sensitivities in rodents. The article provides a brief overview of the diagnostic utility of electrophysiological testing for identifying toxic damage to the peripheral nervous system. The following tests are recommended as a minimum list of primary screening techniques for detecting neurotoxic side effects in study animals: a resting posture assessment, the beam walking test, the horizontal bar test, the digit abduction score assay, the tail flick test, and the Preyer reflex test.</p></sec><sec><title>CONCLUSIONS</title><p>CONCLUSIONS. The results of a comprehensive assessment of neurological deficits in rodent experiments should be analysed from a clinically relevant perspective— that is, with a focus on topical diagnosis and common pathological process components. It is advisable to verify the pathological process at the level of the peripheral nervous system using a set of electrophysiological techniques.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>нейротоксичность</kwd><kwd>лабораторные животные</kwd><kwd>фармакологическая безопасность</kwd><kwd>клинико-функциональные тесты</kwd><kwd>полинейропатия</kwd><kwd>миастенический синдром</kwd><kwd>тест сужающаяся дорожка</kwd><kwd>тест подтягивание на горизонтальной перекладине</kwd><kwd>шкала отведения пальцев</kwd><kwd>тест отдергивания хвоста</kwd><kwd>рефлекс Прейера</kwd><kwd>грызуны</kwd><kwd>исследования на грызунах</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neurotoxicity</kwd><kwd>laboratory animals</kwd><kwd>safety pharmacology</kwd><kwd>clinical functional testing</kwd><kwd>polyneuropathy</kwd><kwd>myasthenic syndrome</kwd><kwd>beam walking test</kwd><kwd>horizontal bar test</kwd><kwd>digit abduction score</kwd><kwd>tail flick test</kwd><kwd>Preyer’s reflex</kwd><kwd>rodents</kwd><kwd>rodent studies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Куценко СА. Основы токсикологии: научно-методическое издание. СПб: Фолиант; 2004. EDN: QKMWIB</mixed-citation><mixed-citation xml:lang="en">Kutsenko SA Fundamentals of toxicology: a scientific and methodological publication. St Petersburg: Foliant; 2004 (In Russ.). EDN: QKMWIB</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Крышень КЛ, Мошков АЕ, Демяновский МН, Ковалева МА. Экспериментальное исследование фармакологической безопасности лекарственных средств, применяемых для купирования лихорадочного синдрома в детском возрасте. Безопасность и риск фармакотерапии. 2020;8(3):151–9. https://doi.org/10.30895/2312-7821-2020-8-3-151-159</mixed-citation><mixed-citation xml:lang="en">Kryshen KL, Moshkov AE, Demyanovskiy MN, Kovaleva MA. Safety pharmacology study of medicines used for febrile syndrome management in children. Safety and Risk of Pharmacotherapy. 2020;8(3):151–9 (In Russ.). https://doi.org/10.30895/2312-7821-2020-8-3-151-159</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Han KS, Woo DH. Classification of advanced me thods for evaluating neurotoxicity. Mol Cell Toxicol. 2021;17(4):377–83. https://doi.org/10.1007/s13273-021-00161-6</mixed-citation><mixed-citation xml:lang="en">Han KS, Woo DH. Classification of advanced me thods for evaluating neurotoxicity. Mol Cell Toxicol. 2021;17(4):377–83. https://doi.org/10.1007/s13273-021-00161-6</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Slater C. Diverse aspects of vulnerability at the neuromuscular junction. Brain. 2012;135(4):997–8. https://doi.org/10.1093/brain/aws057</mixed-citation><mixed-citation xml:lang="en">Slater C. Diverse aspects of vulnerability at the neuromuscular junction. Brain. 2012;135(4):997–8. https://doi.org/10.1093/brain/aws057</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stubbs EB Jr. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies. Exp Neurol. 2020;331:113385. https://doi.org/10.1016/j.expneurol.2020.113385</mixed-citation><mixed-citation xml:lang="en">Stubbs EB Jr. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies. Exp Neurol. 2020;331:113385. https://doi.org/10.1016/j.expneurol.2020.113385</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021;10(7):1537. https://doi.org/10.3390/jcm10071537</mixed-citation><mixed-citation xml:lang="en">Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021;10(7):1537. https://doi.org/10.3390/jcm10071537</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, et al. Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol. 2020;15(1):38–48. https://doi.org/10.2174/1574884714666190121154813</mixed-citation><mixed-citation xml:lang="en">Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, et al. Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol. 2020;15(1):38–48. https://doi.org/10.2174/1574884714666190121154813</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Misra UK, Kalita J. Toxic neuropathies. Neurol India. 2009;57(6):697–705. https://doi.org/10.4103/0028-3886.59463</mixed-citation><mixed-citation xml:lang="en">Misra UK, Kalita J. Toxic neuropathies. Neurol India. 2009;57(6):697–705. https://doi.org/10.4103/0028-3886.59463</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pellacani C, Eleftheriou G. Neurotoxicity of antineoplastic drugs: mechanisms, susceptibility, and neuroprotective strategies. Adv Med Sci. 2020;65(2):265–85. https://doi.org/10.1016/j.advms.2020.04.001</mixed-citation><mixed-citation xml:lang="en">Pellacani C, Eleftheriou G. Neurotoxicity of antineoplastic drugs: mechanisms, susceptibility, and neuroprotective strategies. Adv Med Sci. 2020;65(2):265–85. https://doi.org/10.1016/j.advms.2020.04.001</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Grisold W, Carozzi VA. Toxicity in peripheral nerves: an overview. Toxics. 2021;9(9):218. https://doi.org/10.3390/toxics9090218</mixed-citation><mixed-citation xml:lang="en">Grisold W, Carozzi VA. Toxicity in peripheral nerves: an overview. Toxics. 2021;9(9):218. https://doi.org/10.3390/toxics9090218</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite M, et al. Lessons learned from the fate of Astra-Zeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419–31. https://doi.org/10.1038/nrd4309</mixed-citation><mixed-citation xml:lang="en">Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite M, et al. Lessons learned from the fate of Astra-Zeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419–31. https://doi.org/10.1038/nrd4309</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chi LH, Burrows AD, Anderson RL. Can preclinical drug development help to predict adverse events in clinical trials? Drug Discov Today. 2022;27(1):257–68. https://doi.org/10.1016/j.drudis.2021.08.010</mixed-citation><mixed-citation xml:lang="en">Chi LH, Burrows AD, Anderson RL. Can preclinical drug development help to predict adverse events in clinical trials? Drug Discov Today. 2022;27(1):257–68. https://doi.org/10.1016/j.drudis.2021.08.010</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Masjosthusmann S, Barenys M, El-Gamal M, Geerts L, Gerosa L, Gorreja A, et al. Literature review and appraisal on alternative neurotoxicity testing methods. EFSA Supporting Publications. 2018;15(4):1410E. https://doi.org/10.2903/sp.efsa.2018.en-1410</mixed-citation><mixed-citation xml:lang="en">Masjosthusmann S, Barenys M, El-Gamal M, Geerts L, Gerosa L, Gorreja A, et al. Literature review and appraisal on alternative neurotoxicity testing methods. EFSA Supporting Publications. 2018;15(4):1410E. https://doi.org/10.2903/sp.efsa.2018.en-1410</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chinn GA, Pearn ML, Vutskits L, Mintz CD, Loepke AW, Lee JJ et al. Standards for preclinical research and publications in developmental anaesthetic neurotoxicity: expert opinion statement from the SmartTots preclinical working group. Br J Anaesth. 2020;124(5):585–93. https://doi.org/10.1016/j.bja.2020.01.011</mixed-citation><mixed-citation xml:lang="en">Chinn GA, Pearn ML, Vutskits L, Mintz CD, Loepke AW, Lee JJ et al. Standards for preclinical research and publications in developmental anaesthetic neurotoxicity: expert opinion statement from the SmartTots preclinical working group. Br J Anaesth. 2020;124(5):585–93. https://doi.org/10.1016/j.bja.2020.01.011</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shih HP, Zhang X, Aronov AM. Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications. Nat Rev Drug Discov. 2017;17(1):19–33. https://doi.org/10.1038/nrd.2017.194</mixed-citation><mixed-citation xml:lang="en">Shih HP, Zhang X, Aronov AM. Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications. Nat Rev Drug Discov. 2017;17(1):19–33. https://doi.org/10.1038/nrd.2017.194</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Александров ИВ, Егорова ЕИ, Васина ЕЮ, Новиков ВК, Матыко ПГ, Галагудза ММ. Экспериментальные исследования на животных в эпоху трансляционной медицины. Какими им быть? Трансляционная медицина. 2017;4(2):52–70. https://doi.org/10.18705/2311-4495-2017-4-2-52-70</mixed-citation><mixed-citation xml:lang="en">Aleksandrov IV, Egorova EI, Vasina EYu, Novikov VK, Matyko PG, Galagudza MM. Animal experiments in the era of translational medicine. What would they be? Translational Medicine. 2017;4(2):52–70 (In Russ.). https://doi.org/10.18705/2311-4495-2017-4-2-52-70</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Llorens J, Li AA, Ceccatelli S, Suñol C. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. Neurotoxicology. 2012;33(4):796–804. https://doi.org/10.1016/j.neuro.2012.01.019</mixed-citation><mixed-citation xml:lang="en">Llorens J, Li AA, Ceccatelli S, Suñol C. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. Neurotoxicology. 2012;33(4):796–804. https://doi.org/10.1016/j.neuro.2012.01.019</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cashman CR, Höke A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett. 2015;596:33–50. https://doi.org/10.1016/j.neulet.2015.01.048</mixed-citation><mixed-citation xml:lang="en">Cashman CR, Höke A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett. 2015;596:33–50. https://doi.org/10.1016/j.neulet.2015.01.048</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hauser S, ed. Harrison’s Neurology in Clinical Medicine. San Francisco: McGraw-Hill; 2010.</mixed-citation><mixed-citation xml:lang="en">Hauser S, ed. Harrison’s Neurology in Clinical Medicine. San Francisco: McGraw-Hill; 2010.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wasinska-Borowiec W, Abri Aghdam K, Matias Saari J, Grzybowski A. An updated review on the most common agents causing toxic optic neuropathies. Current Pharm Des. 2017;23(4):586–95. https://doi.org/10.2174/1381612823666170124113826</mixed-citation><mixed-citation xml:lang="en">Wasinska-Borowiec W, Abri Aghdam K, Matias Saari J, Grzybowski A. An updated review on the most common agents causing toxic optic neuropathies. Current Pharm Des. 2017;23(4):586–95. https://doi.org/10.2174/1381612823666170124113826</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lindhard Madsen M, Du H, Ejskjær N, Jensen P, Madsen J, Dybkær K. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol. 2019;84(3):471–85. https://doi.org/10.1007/s00280-019-03884-5</mixed-citation><mixed-citation xml:lang="en">Lindhard Madsen M, Du H, Ejskjær N, Jensen P, Madsen J, Dybkær K. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol. 2019;84(3):471–85. https://doi.org/10.1007/s00280-019-03884-5</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Одинак ММ, Дыскин ДЕ. Клиническая диагностика в неврологии. СПб: СпецЛит; 2010. EDN: QLVPQP</mixed-citation><mixed-citation xml:lang="en">Odinak MM, Dyskin DE. Clinical diagnostics in neurology. St Petersburg: SpetsLit; 2010 (In Russ.). EDN: QLVPQP</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tilson HA. Behavioral indices of neurotoxicity: what can be measured? Neurotoxicol Teratol. 1987;9(6):427–43. https://doi.org/10.1016/0892-0362(87)90055-9</mixed-citation><mixed-citation xml:lang="en">Tilson HA. Behavioral indices of neurotoxicity: what can be measured? Neurotoxicol Teratol. 1987;9(6):427–43. https://doi.org/10.1016/0892-0362(87)90055-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Schönfeld LM, Dooley D, Jahanshahi A, Temel Y, Hendrix S. Evaluating rodent motor functions: which tests to choose? Neurosci Biobehav Rev. 2017;83:298–312. https://doi.org/10.1016/j.neubiorev.2017.10.021</mixed-citation><mixed-citation xml:lang="en">Schönfeld LM, Dooley D, Jahanshahi A, Temel Y, Hendrix S. Evaluating rodent motor functions: which tests to choose? Neurosci Biobehav Rev. 2017;83:298–312. https://doi.org/10.1016/j.neubiorev.2017.10.021</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ. Delaying the onset of Huntington’s in mice. Nature. 2000;404:721–22. https://doi.org/10.1038/35008142</mixed-citation><mixed-citation xml:lang="en">van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ. Delaying the onset of Huntington’s in mice. Nature. 2000;404:721–22. https://doi.org/10.1038/35008142</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Deacon RM. Measuring motor coordination in mice. J Vis Exp. 2013;75:e2609. https://doi.org/10.3791/2609</mixed-citation><mixed-citation xml:lang="en">Deacon RM. Measuring motor coordination in mice. J Vis Exp. 2013;75:e2609. https://doi.org/10.3791/2609</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Воронина ТА, Середенин СБ. Методические указания по изучению транквилизирующего (анксиолитического) действия фармакологических веществ. В кн.: Хабриев РУ, ред. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Медицина; 2005. EDN: QCIIOB</mixed-citation><mixed-citation xml:lang="en">Voronina TA, Seredenin SB. Methodological guidelines for the study of the tranquilizing (anxiolytic) effect of pharmacological substances. In: Khabriev RU, ed. Guidelines for the experimental (preclinical) study of new pharmacological substances. Moscow: Meditsina; 2005 (In Russ.). EDN: QCIIOB</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ахапкина ВИ, Воронина ТА. Изучение противоинсультного действия фенотропила на модели геморрагического инсульта (интрацеребральная посттравматическая гематома) у крыс. Нервные болезни. 2006;(1):37–42. EDN: OOKJEX</mixed-citation><mixed-citation xml:lang="en">Akhapkina VI, Voronina TA. Study of the anti-stroke effect of phenotropil in a rat hemorrhagic stroke model (post-traumatic intracerebral hematoma). Nervous Diseases. 2006;(1):37–42 (In Russ.). EDN: OOKJEX</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user’s guide. Nat Rev Neurosci. 2009;10(7):519–29. https://doi.org/10.1038/nrn2652</mixed-citation><mixed-citation xml:lang="en">Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user’s guide. Nat Rev Neurosci. 2009;10(7):519–29. https://doi.org/10.1038/nrn2652</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Takeshita H, Yamamoto K, Nozato S, Inagaki T, Tsuchimochi H, Shirai M, et al. Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice. Sci Rep. 2017;(7):42323. https://doi.org/10.1038/srep42323</mixed-citation><mixed-citation xml:lang="en">Takeshita H, Yamamoto K, Nozato S, Inagaki T, Tsuchimochi H, Shirai M, et al. Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice. Sci Rep. 2017;(7):42323. https://doi.org/10.1038/srep42323</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Mintz EL, Passipieri JA, Lovell DY, Christ GJ. Applications of in vivo functional testing of the rat tibialis anterior for evaluating tissue engineered skeletal muscle repair. J Vis Exp. 2016;(116):54487. https://doi.org/10.3791/54487</mixed-citation><mixed-citation xml:lang="en">Mintz EL, Passipieri JA, Lovell DY, Christ GJ. Applications of in vivo functional testing of the rat tibialis anterior for evaluating tissue engineered skeletal muscle repair. J Vis Exp. 2016;(116):54487. https://doi.org/10.3791/54487</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chiu CS, Weber H, Adamski S, Rauch A, Gentile MA, Alves SE. Non-invasive muscle contraction assay to study rodent models of sarcopenia. BMC Musculoskelet Disord. 2011;12:246. https://doi.org/10.1186/1471-2474-12-246</mixed-citation><mixed-citation xml:lang="en">Chiu CS, Weber H, Adamski S, Rauch A, Gentile MA, Alves SE. Non-invasive muscle contraction assay to study rodent models of sarcopenia. BMC Musculoskelet Disord. 2011;12:246. https://doi.org/10.1186/1471-2474-12-246</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Чичева ММ, Вихарева ЕВ, Мальцев АВ, Устюгов АА. Эволюция методик оценки моторной функции лабораторных грызунов, моделирующих нейродегенеративные заболевания. Biomed Chem Res Meth. 2018;1(3):e00030. https://doi.org/10.18097/bmcrm00030</mixed-citation><mixed-citation xml:lang="en">Chicheva MM, Vikhareva EV, Maltsev AV, Ustyugov AA. Evolution of methods for assessing the motor function of laboratory rodents — neurodegenerative diseases models. Biomed Chem Res Meth. 2018;1(3):e00030 (In Russ.). https://doi.org/10.18097/bmcrm00030</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hsieh TH, Tsai JY, Wu YN, Hwang IS, Chen TI, Chen JJJ. Time course quantification of spastic hypertonia following spinal hemisection in rats. Neuroscience. 2010;167(1):185–98. https://doi.org/10.1016/j.neuroscience.2010.01.064</mixed-citation><mixed-citation xml:lang="en">Hsieh TH, Tsai JY, Wu YN, Hwang IS, Chen TI, Chen JJJ. Time course quantification of spastic hypertonia following spinal hemisection in rats. Neuroscience. 2010;167(1):185–98. https://doi.org/10.1016/j.neuroscience.2010.01.064</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ильинский НС, Тюнин МА, Матросова МО. Методические подходы к оценке паралитического синдрома токсического генеза в экспериментах на грызунах. Лабораторные животные для научных исследований. 2021;(3):71–4. https://doi.org/10.29296/2618723X-2021-03-09</mixed-citation><mixed-citation xml:lang="en">Ilinskiy NS, Tyunin MA, Matrosova MO. Methodological approaches to the assessment of paralytic syndrome of toxic genesis in experiments on rodents. Laboratory Animals for Science. 2021;(3):71–4 (In Russ.). https://doi.org/10.29296/2618723X-2021-03-09</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Aoki KR. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon. 2001;39(12):1815–20. https://doi.org/10.1016/s0041-0101(01)00101-5</mixed-citation><mixed-citation xml:lang="en">Aoki KR. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon. 2001;39(12):1815–20. https://doi.org/10.1016/s0041-0101(01)00101-5</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Broide RS, Rubino J, Nicholson GS, Ardila MC, Brown MS, Aoki KR, et al. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxininduced skeletal muscle paralysis. Toxicon. 2013;71:18–24. https://doi.org/10.1016/j.toxicon.2013.05.004</mixed-citation><mixed-citation xml:lang="en">Broide RS, Rubino J, Nicholson GS, Ardila MC, Brown MS, Aoki KR, et al. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxininduced skeletal muscle paralysis. Toxicon. 2013;71:18–24. https://doi.org/10.1016/j.toxicon.2013.05.004</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Nishitani A, Yoshihara T, Tanaka M, Kuwamura M, Asano M, Tsubota Y, et al. Muscle weakness and impaired motor coordination in hyperpolarization-activated cyclic nucleotide-gated potassium channel 1-deficient rats. Exp Anim. 2020;69(1):11–7. https://doi.org/10.1538/expanim.19-0067</mixed-citation><mixed-citation xml:lang="en">Nishitani A, Yoshihara T, Tanaka M, Kuwamura M, Asano M, Tsubota Y, et al. Muscle weakness and impaired motor coordination in hyperpolarization-activated cyclic nucleotide-gated potassium channel 1-deficient rats. Exp Anim. 2020;69(1):11–7. https://doi.org/10.1538/expanim.19-0067</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Turner PV, Pang DS, Lofgren JL. A review of pain assessment methods in laboratory rodents. Comp Med. 2019;69(6):451–67. https://doi.org/10.30802/AALAS-CM-19-000042</mixed-citation><mixed-citation xml:lang="en">Turner PV, Pang DS, Lofgren JL. A review of pain assessment methods in laboratory rodents. Comp Med. 2019;69(6):451–67. https://doi.org/10.30802/AALAS-CM-19-000042</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284. https://doi.org/10.3389/fnmol.2017.00284с</mixed-citation><mixed-citation xml:lang="en">Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284. https://doi.org/10.3389/fnmol.2017.00284с</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Modi AD, Parekh A, Pancholi YN. Evaluating pain behaviours: widely used mechanical and thermal methods in rodents. Behav Brain Res. 2023;446:114417. https://doi.org/10.1016/j.bbr.2023.114417</mixed-citation><mixed-citation xml:lang="en">Modi AD, Parekh A, Pancholi YN. Evaluating pain behaviours: widely used mechanical and thermal methods in rodents. Behav Brain Res. 2023;446:114417. https://doi.org/10.1016/j.bbr.2023.114417</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Bohic M, Pattison LA, Jhumka ZA. Mapping the neuroethological signatures of pain, analgesia, and recovery in mice. Neuron. 2023;111(18):2811–2830.e8. https://doi.org/10.1016/j.neuron.2023.06.008</mixed-citation><mixed-citation xml:lang="en">Bohic M, Pattison LA, Jhumka ZA. Mapping the neuroethological signatures of pain, analgesia, and recovery in mice. Neuron. 2023;111(18):2811–2830.e8. https://doi.org/10.1016/j.neuron.2023.06.008</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Presto P, Ji G, Junell R, Griffin Z, Neugebauer V. Fear extinction-based inter-individual and sex differences in pain-related vocalizations and anxiety-like behaviors but not nocifensive reflexes. Brain Sci. 2021;11(10):1339. https://doi.org/10.3390/brainsci11101339</mixed-citation><mixed-citation xml:lang="en">Presto P, Ji G, Junell R, Griffin Z, Neugebauer V. Fear extinction-based inter-individual and sex differences in pain-related vocalizations and anxiety-like behaviors but not nocifensive reflexes. Brain Sci. 2021;11(10):1339. https://doi.org/10.3390/brainsci11101339</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Palazzo E, Marabese I, Gargano F, Guida F, Belardo C, Maione S. Methods for evaluating sensory, affective and cognitive disorders in neuropathic rodents. Curr Neuropharmacol. 2021;19(6):736–46. https://doi.org/10.2174/1570159X18666200831153117</mixed-citation><mixed-citation xml:lang="en">Palazzo E, Marabese I, Gargano F, Guida F, Belardo C, Maione S. Methods for evaluating sensory, affective and cognitive disorders in neuropathic rodents. Curr Neuropharmacol. 2021;19(6):736–46. https://doi.org/10.2174/1570159X18666200831153117</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Chao D, Tran H, Hogan QH, Pan B. Analgesic dorsal root ganglion field stimulation blocks both afferent and efferent spontaneous activity in sensory neurons of rats with monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2022;30(11):1468–81. https://doi.org/10.1016/j.joca.2022.08.008</mixed-citation><mixed-citation xml:lang="en">Chao D, Tran H, Hogan QH, Pan B. Analgesic dorsal root ganglion field stimulation blocks both afferent and efferent spontaneous activity in sensory neurons of rats with monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2022;30(11):1468–81. https://doi.org/10.1016/j.joca.2022.08.008</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко ДА, Дьяченко ИА, Скобцов ДИ, Мурашев АН. In vivo модели для изучения анальгетической активности. Биомедицина. 2011;(2):84–94. EDN: NVYEMF</mixed-citation><mixed-citation xml:lang="en">Bondarenko DA, Dyachenko IA, Skobtsov DI, Murashev AN. In vivo models of studying of analgetic activity. Biomedicine. 2011;(2):84–94 (In Russ.). EDN: NVYEMF</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q, Liu J, Guo M. Comparison of retinal degeneration treatment with four types of different mesenchymal stem cells, human induced pluripotent stem cells and RPE cells in a rat retinal degeneration model. J Transl Med. 2023;21(1):910. https://doi.org/10.1186/s12967-023-04785-1</mixed-citation><mixed-citation xml:lang="en">Liu Q, Liu J, Guo M. Comparison of retinal degeneration treatment with four types of different mesenchymal stem cells, human induced pluripotent stem cells and RPE cells in a rat retinal degeneration model. J Transl Med. 2023;21(1):910. https://doi.org/10.1186/s12967-023-04785-1</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gaillard D, Stratford JM. Measurement of behavioral taste responses in mice: two-bottle preference, lickometer, and conditioned taste-aversion tests. Curr Protoc Mouse Biol. 2016;6(4):380–407. https://doi.org/10.1002/cpmo.18</mixed-citation><mixed-citation xml:lang="en">Gaillard D, Stratford JM. Measurement of behavioral taste responses in mice: two-bottle preference, lickometer, and conditioned taste-aversion tests. Curr Protoc Mouse Biol. 2016;6(4):380–407. https://doi.org/10.1002/cpmo.18</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">McFadden SL, Simmons AM, Erbe C, Thomas JA. Behavioral and physiological audiometric methods for animals. In: Erbe C, Thomas JA, eds. Exploring animal behavior through sound. Springer; 2022. https://doi.org/10.1007/978-3-030-97540-1_10</mixed-citation><mixed-citation xml:lang="en">McFadden SL, Simmons AM, Erbe C, Thomas JA. Behavioral and physiological audiometric methods for animals. In: Erbe C, Thomas JA, eds. Exploring animal behavior through sound. Springer; 2022. https://doi.org/10.1007/978-3-030-97540-1_10</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Arevalo N. Open-source JL olfactometer for awake behaving recording of brain activity for mice engaged in olfactory tasks. In: Paredes RG, Portillo W, Bedos M, eds. Animal models of reproductive behavior. New York: Humana; 2023. https://doi.org/10.1007/978-1-0716-3234-5_6</mixed-citation><mixed-citation xml:lang="en">Arevalo N. Open-source JL olfactometer for awake behaving recording of brain activity for mice engaged in olfactory tasks. In: Paredes RG, Portillo W, Bedos M, eds. Animal models of reproductive behavior. New York: Humana; 2023. https://doi.org/10.1007/978-1-0716-3234-5_6</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Oxford University Press; 2013. https://doi.org/10.1093/med/9780199738687.001.0001</mixed-citation><mixed-citation xml:lang="en">Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Oxford University Press; 2013. https://doi.org/10.1093/med/9780199738687.001.0001</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Тюнин МА, Ильинский НС, Гоголевский АС, Кручинин ЕГ, Гладких ВД, Мацейчик ВА, Матросова МО. Электрофизиологические методы диагностики нарушений нервно-мышечной передачи при острых отравлениях фосфорорганическими соединениями. Военно-медицинский журнал. 2020;341(10):11–9. EDN: NSYNCD</mixed-citation><mixed-citation xml:lang="en">Tyunin MA, Ilinskii NS, Gogolevskii AS, Kruchinin EG, Gladkikh VD, Matseichik VA, Matrosova MO. Electrophysiological methods for the diagnosis of disorders of neuromuscular transmission in acute poisoning with organophosphorus compounds. Russian Military Medical Journal. 2020;341(10):11–9 (In Russ.). EDN: NSYNCD</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
